Electronic Health Record Augmented LDL-Cholesterol Optimization and Control Via Active Lipid Engagement (EHR-LOCALE): A Quality Improvement Implementation Study

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorUniversity of Alberta

About this trial

The purpose of this study is to determine whether a proactive, EHR-guided approach helps more individuals reach safe cholesterol levels, improves medication use, and reduces future heart attacks and strokes, compared to usual care.

The main question it aims to answer is:

• Does the EHR-LOCALE pathway increases the proportion of patients who reach the LDL-cholesterol target of \<1.8 mmol/L at 6 months?

Participants in the interventional group receive:

* Pharmacist contact * Repeat lipid requisitions * Review of medications, adherence, and side effects * Treatment escalation according to national dyslipidemia guidelines

Eligibility criteria

Qualifiers

Adults over the age of 18

Resident of Alberta

Individuals hospitalized with an acute coronary syndrome and have undergone coronary angiography.

Able to participate in follow-up contact if randomized to the intervention arm

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Pharmacist-led lipid optimization pathway

Treatment groups

2,000 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators